AMRX
ALKS

Alva Emily Peterson

Known title: DirectorCIK: 0001738422

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 8, 2026

AMRX Gains Fair Value Bump After Analyst Support for New Launches. Analysts have raised AMRX's fair value after backing new product launches, lifting the stock's target range. The company is listed among low‑volatility stocks that still have open questions for investors. The move comes as the shares trade near the middle of their 52‑week range and around the 53.3 RSI level.

this person other insiders at AMRX

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 6, 2026

Baird Highlights Growth Potential for Alkermes plc (ALKS). Baird has highlighted Alkermes plc as a company with promising growth potential, citing its pipeline and recent developments. A Yahoo article compares Alkermes to LQDA, discussing which biotech may be more attractive for investors. The stock is currently trading near its 200‑day moving average and close to a key support level of $48.74, while analysts average a target of $56.56.

this person other insiders at ALKS

Transaction History

AMRX▲ Buy—
AMRX▼ Sell$712K
ALKS▲ Buy—
ALKS▼ Sell$35K
ALKS▲ Buy—
ALKS▼ Sell$22K
AMRX▲ Buy—
ALKS▲ Buy—
ALKS▼ Sell$43K
ALKS▲ Buy—
ALKS▼ Sell$28K
AMRX▲ Buy—
ALKS▼ Sell$25K
ALKS▲ Buy—
ALKS▼ Sell$1K
ALKS▲ Buy—
ALKS▼ Sell$9K
ALKS▲ Buy—
AMRX▲ Buy—

We use analytics to understand how market-wall is used. No personal data is sold.